An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D000818:Animals; D001323:Autoantibodies / Q000097:blood; D002216:Captopril / Q000494:pharmacology*; D002908:Chronic Disease; D016207:Cytokines / Q000378:metabolism; D015870:Gene Expression / Q000187:drug effects; D016753:Interleukin-10 / Q000378:metabolism; D015847:Interleukin-4 / Q000378:metabolism; D007668:Kidney / Q000187:drug effects / Q000502:physiology; D008181:Lupus Nephritis / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control; D051379:Mice; D008807:Mice, Inbred BALB C; D019463:Mice, Inbred MRL lpr; D008814:Mice, Inbred NZB; D012333:RNA, Messenger / Q000032:analysis; D013154:Spleen / Q000187:drug effects / Q000378:metabolism; D018418:Th2 Cells / Q000187:drug effects* / Q000378:metabolism; D016212:Transforming Growth Factor beta / Q000097:blood / Q000235:genetics* / Q000378:metabolism; D053773:Transforming Growth Factor beta1; D053781:Transforming Growth Factor beta2
D000806:Angiotensin-Converting Enzyme Inhibitors; D001323:Autoantibodies; D016207:Cytokines; D012333:RNA, Messenger; C508961:Tgfb1 protein, mouse; D016212:Transforming Growth Factor beta; D053773:Transforming Growth Factor beta1; D053781:Transforming Growth Factor beta2; D016753:Interleukin-10; D015847:Interleukin-4; D002216:Captopril